Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor

NCT02989519 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 231

Last updated 2017-10-10

No results posted yet for this study

Summary

The purpose of this study is to determine efficacy of vaginal and oral progesterone after tocolytic therapy in threatened preterm labor

Conditions

  • Preterm Delivery

Interventions

DRUG

dydrogesterone

DRUG

Micronized progesterone

Sponsors & Collaborators

  • Sanpasitthiprasong Hospital

    lead OTHER_GOV

Principal Investigators

  • Piyawadee Wuttikonsammakit, MD · Instructor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-01-05
Completion
2017-03-01

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02989519 on ClinicalTrials.gov